US Expansion Opportunity Xellia has expanded manufacturing capability to Cleveland, Ohio to begin commercial production. This creates a strong opening for end-to-end manufacturing partnerships, including sterile fill-finish services, equipment supply, process optimization, and cold-chain logistics to support US-market supply continuity.

Supply Continuity Partnerships The company emphasizes supply reliability as a core value and long-term partnerships. There is an opportunity to pursue strategic supplier arrangements, risk management, dual sourcing, and quality alliance programs to ensure consistent anti-infective availability.

Cybersecurity and Compliance Xellia lists CISSP and GDPR among its tech stack, signaling a strong focus on information security and data privacy in manufacturing. This aligns with opportunities in GMP IT/OT integration, cybersecurity for manufacturing operations, data integrity solutions, and cross-border regulatory compliance support.

Fermentation Excellence Growth With a long-standing focus on fermentation-based anti-infectives, Xellia’s model relies on deep process development, technology transfer, scale-up, and regulatory readiness. Potential to offer contract development and manufacturing services, analytics, stability testing, and optimization of fermentation processes.

Leadership Engagement A recent leadership transition with a new CEO presents a natural entry point for high-level partnerships and co-development opportunities. Engage with the executive team to discuss strategic collaborations, capacity expansion plans, and long-term supply agreements.